UK patient capital today announces a $50.8 million commitment to the Third Fund. Evolution Equity Partnersa specialized technology investor focused on cybersecurity and enterprise software companies.
Evolution Equity Partners' previous investments include: quantexaa global data and analytics software company that achieved unicorn status in 2023; Panasealan enterprise security platform.
British Patient Capital’s investment follows a $35 million commitment to Evolution’s second fund in 2020.
Robert Greenwood, Fund Investment Director at British Patient Capital, said:
“Cybersecurity began as a niche subsector of technology. Widespread adoption and advancements in technology have expanded the attack surface as companies seek to protect themselves, their customers, and their products. We have seen the technology evolve over the past 20 years as applications become increasingly popular.
This investment demonstrates the UK’s role in leading cybersecurity innovation and demonstrating expertise in this valuable technology. ”
said Richard Seewald, Founder and Managing Partner of Evolution Equity Partners.
“We are excited to partner with British Patient Capital and NSSIF to support UK-based cybersecurity companies with capital and provide them with the knowledge, tools and strategies to drive performance and results in global markets. I am.
Cybersecurity is critical to the safety of UK-based businesses, governments and consumers, and the current environment has demonstrated the importance of next-generation technology to protect and protect our society and way of life. ”
Lead image: Marcus Spike.
